Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for Cresco Labs (CRLBF) over the last 4 years, with Q3 2025 value amounting to $50.1 million.

  • Cresco Labs' Accumulated Expenses fell 1717.89% to $50.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.1 million, marking a year-over-year decrease of 1717.89%. This contributed to the annual value of $54.3 million for FY2024, which is 2140.01% down from last year.
  • According to the latest figures from Q3 2025, Cresco Labs' Accumulated Expenses is $50.1 million, which was down 1717.89% from $54.4 million recorded in Q2 2025.
  • Cresco Labs' Accumulated Expenses' 5-year high stood at $96.0 million during Q1 2022, with a 5-year trough of $50.1 million in Q3 2025.
  • In the last 4 years, Cresco Labs' Accumulated Expenses had a median value of $56.1 million in 2025 and averaged $61.9 million.
  • In the last 5 years, Cresco Labs' Accumulated Expenses crashed by 2140.01% in 2024 and then increased by 15.09% in 2025.
  • Cresco Labs' Accumulated Expenses (Quarter) stood at $96.0 million in 2022, then dropped by 28.01% to $69.1 million in 2023, then fell by 21.4% to $54.3 million in 2024, then fell by 7.74% to $50.1 million in 2025.
  • Its Accumulated Expenses was $50.1 million in Q3 2025, compared to $54.4 million in Q2 2025 and $56.1 million in Q1 2025.